Down 79%, Is Moderna Stock a Bad-News Buy on the Dip?
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...
The fight to replace Justin Trudeau is on
Mark Carney has run two central banks and championed the green transition. Now he wants to lead Canada’s Liberal Party.